Giulia Simini: Acquired von Willebrand Syndrome and Coagulation Abnormalities in MPN-Associated Thrombocytosis
Giulia Simini, Resident doctor in Hematology at NHS England, shared a post on LinkedIn about a recent article she and her colleagues co-authored, adding:
“Just published on RPTH!
Acquired von Willebrand syndrome is a often underdiagnosed and misdiagnosed complication of MPNs.
In this cohort of MPN patients with thrombocytosis, 33 percent developed bleeding complications.
However, platelets count alone was not a predictor of bleeding risk.
Interestingly, we found a significant correlation between vWF:RCo/Ag ratio and PT, as well as APTT.
This potentially suggests other coagulation imbalances in patients with MPNs.
One patient was found to have FV deficiency and dysfibrinogenemia.
A tailored approach is essential to assess bleeding risk in this cohort.”
Title: Thrombocytosis and bleeding in myeloproliferative neoplasms: exploring clinical diversity and risk of acquired von Willebrand syndrome—insights from a UK center
Authors: Giulia Simini, Andrew Innes, Saravanan Vinayagam, Golzar Mobayen, Nilanthi Karawitage, Simone Claudiani, Zain Odho, Mike Laffan, Deepa J. Arachchillage
Read the Full Article on RPTH.

Other posts featuring Giulia Simini on Hemostasis Today.
-
May 24, 2026, 16:12William Wallace: Normal B12 Levels May Still Cause Brain Damage and Cognitive Decline
-
May 24, 2026, 15:54Marc Carrier: Ottawa Race Weekend Raised Over 7,000 USD for Thrombosis Canada
-
May 24, 2026, 15:44Janak Sadhu: Building a Stroke-Free Mehsana Through Community Awareness and Healthcare Collaboration
-
May 24, 2026, 15:33Mohammed Zubair: AI-Driven Innovation in Stroke Diagnosis and Medical Imaging
-
May 24, 2026, 14:26Salome Mekhuzla: World Health Assembly Adopts Historic Global Resolution for Hemophilia and Bleeding Disorders
-
May 24, 2026, 13:10Thomas Pincez: Emerging Challenges in Sickle Cell Disease Gene Therapy and Cancer Risk
-
May 24, 2026, 12:04Kalpana Gupta Shekhawat: Ferritin Is More Than an Iron Marker
-
May 24, 2026, 11:50Peter Zdziarski: Making Rare Disease Research More Human
-
May 24, 2026, 11:39Bram Berkelmans: Donating with a View